Invention Grant
- Patent Title: Integrin ligands and uses thereof
-
Application No.: US16759610Application Date: 2018-10-31
-
Publication No.: US11597701B2Publication Date: 2023-03-07
- Inventor: Zhen Li , Xiaokai Li , Erik W. Bush , Rui Zhu , Dongxu Shu , Jonathan Benson , Patrick Shao , Matthew Fowler-Watters
- Applicant: Arrowhead Pharmaceuticals, Inc.
- Applicant Address: US CA Pasadena
- Assignee: Arrowhead Pharmaceuticals, Inc.
- Current Assignee: Arrowhead Pharmaceuticals, Inc.
- Current Assignee Address: US CA Pasadena
- Agent Paul VanderVelde; Robert M. Teigen; Meibo Chen
- International Application: PCT/US2018/058471 WO 20181031
- International Announcement: WO2019/089765 WO 20190509
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C07D213/74 ; C07D409/12 ; C07D413/12 ; A61K47/54 ; A61K47/56 ; A61K47/60 ; C12N15/11 ; C12N15/113

Abstract:
Synthetic αvβ6 integrin ligands of Formula I having serum stability and affinity for integrin αvβ6, which is a receptor expressed in a variety of cell types, are described. The described ligands are useful for delivering cargo molecules, such as RNAi agents or other oligonucleotide-based compounds, to cells that express integrin αvβ6, and thereby facilitating the uptake of the cargo molecules into these cells. Compositions that include αvβ6 integrin ligands and methods of use are also described.
Public/Granted literature
- US20200369613A1 INTEGRIN LIGANDS AND USES THEREOF Public/Granted day:2020-11-26
Information query